The Tumor-immune Index is Correlated With the Prognosis of Patients After Curative Resection for Nonsmall Cell Lung Cancer

We developed a novel tumor-immune index (TII) based on carcinoembryonic antigen levels, lymphocyte counts, and platelet counts, and explored its prognostic value in nonsmall cell lung cancer (NSCLC). The prognostic value of the TII was evaluated based on a retrospective study of 205 patients with ea...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Bobo, Liu, Jie, Feng, Rui, Guo, Hongbo, Liu, Shuguang, Li, Daotang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
7100
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674204/
https://www.ncbi.nlm.nih.gov/pubmed/26632901
http://dx.doi.org/10.1097/MD.0000000000002174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674204/
https://www.ncbi.nlm.nih.gov/pubmed/26632901
http://dx.doi.org/10.1097/MD.0000000000002174

Ejemplares similares